Articles published by Axsome Therapeutics, Inc.
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 05, 2024
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
June 05, 2024
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 20, 2024
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20
January 23, 2024
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today
December 07, 2023
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Axsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
November 06, 2023
Via GlobeNewswire
Tickers
AXSM
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Axsome Therapeutics to Present at Upcoming Investor Conferences
October 31, 2023
Via GlobeNewswire
Tickers
AXSM
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.